Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 258 results for "angel broking ltd"

Your Stocks: Top chart picks to stay invested
Money Control

Your Stocks: Top chart picks to stay invested

Watch the interview of Kunal Saraogi, CEO of Equityrush and Mayuresh Joshi, VP- Institution of Angel Broking Ltd with Sumaira Abidi Nigel D'Souza on CNBC-TV18, in which they shared their reading and outlook on market and specific stocks. Money Control, 2 days ago
Your Stocks: Top chart picks by market experts Money Control, 1 week ago

Accumulate Maruti Suzuki; target of Rs 3750: Angel Broking

Angel Broking`s research report on Maruti Suzuki India Maruti Suzuki India Ltd (MSIL)'s 2QFY2015 results were ahead of our estimates due to higher other income and lower taxation even as the operating performance was inline. Revenues grew strongly ...
 Moneycontrol.com1 week ago Buy Crompton Greaves; target of Rs 235: Angel Broking  Moneycontrol.com3 weeks ago Maruti Suzuki India : sees 10% growth on rising urban demand  4 Traders2 weeks ago

Billionaire Kotak's Bank Buys ING Vysya in Record India Deal

(Updates pricing in second paragraph.) Nov. 20 (Bloomberg) -- Billionaire Uday Kotak's Kotak Mahindra Bank Ltd. agreed to acquire ING Vysya Bank Ltd. in India's biggest banking takeover. Kotak Mahindra will pay 725 shares for every 1,000 shares of ...
 Washington Post20 hours ago Billionaire Kotak Buys ING Vysya in Biggest Indian Bank Takeover  GARP13 hours ago India biggest bank deal: Tycoon Kotak buys ING Vysya  Malay Mail9 hours ago Kotak Buys ING Vysya in Biggest Indian Bank Takeover  La Repubblica10 hours ago
Business Standard India

US growth & domestic business boost Sun Pharma's numbers

Related to : Sun Pharmaceuticals Industries Ltd Sun Pharmaceuticals Industries Ltd BSE 13 Nov 14 | 12:00 AM 908.60 2.35 (0.26%) NSE 13 Nov 14 | 12:00 AM 908.30 2.25 (0.25%) Sun Pharmaceutical reported a good set of numbers for ...
 Business Standard India1 week ago Aurobindo Pharma to acquire Natrol for $132.5 million  India Brand Equity Foundation1 week ago Aurobindo to buy US nutritional supplements maker for $133 million  Sify1 week ago Aurobindo highest bidder for Natrol, scrip rises  Business Standard India1 week ago

Infosys marginally in red as BPO unit sacks CFO Abraham Mathews

NEW DELHI: Infosys Ltd slipped pared its morning gains and turned negative in trade on Wednesday, after Infosys BPO Ltd has asked its Chief Financial Officer (CFO) Abraham Mathews to resign from the service for not complying with the code of conduct ...
 Economic Times2 days ago Infosys Q2 results: Should you buy the stock now?  Business Standard India1 month ago Infosys hits record high  Business Standard India1 month ago

Ranbaxy sues USFDA for revoking drug approvals

For long at the receiving end, Ranbaxy Laboratories Ltd has chosen to go on the offensive against the United States Food and Drug Administration (USFDA), suing the US regulator for revoking tentative approvals given to it six years ago to launch ...
 Hindu Business Line2 days ago Ranbaxy Laboratories : sues FDA for revoking approvals  4 Traders18 hours ago Double blow to Ranbaxy  Calcutta Telegraph2 weeks ago

Japan Stocks On The Rise As Yen Hits Post-crisis Low

LOS ANGELES Japanese stocks started modestly higher Wednesday but quickly added to gains as the yen trudged further downhill. The Nikkei Stock Average sat 0.5% higher about half an hour into the session, and the Topix was up 0.8%, as the dollar ...
 FOXBusiness.com2 days ago

Can BSE challenge MCX's monopoly in commodities trading?

It's been about 15 months since the National Spot Exchange Ltd (NSEL) scam rocked India's commodity markets. Multi Commodity Exchange of India Ltd's (MCX's) volumes have fallen sharply, both as a result of the scam as well as the imposition of ...
 Livemint.com3 days ago Commexes' turnover falls to five-year low  Business Standard India1 month ago

Tata Motors Profit Misses Estimates as Land Rover Sales Slow

Nov. 14 (Bloomberg) -- Tata Motors Ltd., India's biggest automaker, posted profit that missed analyst estimates as sales growth at its Jaguar Land Rover unit slowed. Net income fell 7 percent to 32.9 billion rupees ($533 million) in the quarter ...
 Washington Post1 week ago

Dishman Pharma consolidated net dips 21% in Q2

Ahmedabad-based contract research and manufacturing services (CRAMS) player Dishman Pharmaceuticals and Chemicals Ltd posted a four-fold rise in net profit on a standalone basis for the quarter ended September 30, 2014 to Rs 25.37 crore on the back ...
 Business Standard India1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less